These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11907182)

  • 1. The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleukin-10.
    Corbel M; Germain N; Lanchou J; Molet S; R e Silva PM; Martins MA; Boichot E; Lagente V
    J Pharmacol Exp Ther; 2002 Apr; 301(1):258-65. PubMed ID: 11907182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice.
    Corbel M; Lanchou J; Germain N; Malledant Y; Boichot E; Lagente V
    Eur J Pharmacol; 2001 Aug; 426(1-2):113-21. PubMed ID: 11525779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of matrix metalloproteinase-9 activity by the selective phosphodiesterase 4 inhibitor, RP 73-401 in sensitized mice.
    Belleguic C; Corbel M; Germain N; Boichot E; Delaval P; Lagente V
    Eur J Pharmacol; 2000 Sep; 404(3):369-73. PubMed ID: 10996602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase type 4 inhibitors cause proinflammatory effects in vivo.
    McCluskie K; Klein U; Linnevers C; Ji YH; Yang A; Husfeld C; Thomas GR
    J Pharmacol Exp Ther; 2006 Oct; 319(1):468-76. PubMed ID: 16861399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p38 MAP kinase in LPS-induced airway inflammation in the rat.
    Haddad EB; Birrell M; McCluskie K; Ling A; Webber SE; Foster ML; Belvisi MG
    Br J Pharmacol; 2001 Apr; 132(8):1715-24. PubMed ID: 11309243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors.
    Martin-Chouly CA; Astier A; Jacob C; Pruniaux MP; Bertrand C; Lagente V
    Life Sci; 2004 Jul; 75(7):823-40. PubMed ID: 15183075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derived from 9-benzyladenine.
    Boichot E; Wallace JL; Germain N; Corbel M; Lugnier C; Lagente V; Bourguignon JJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):647-53. PubMed ID: 10640302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of Mesocestoides corti-infected BALB/c mice by phosphodiesterase 4 inhibitors.
    Souness JE; Houghton C; Sardar N; Withnall MT
    Biochem Pharmacol; 1999 Sep; 58(6):991-9. PubMed ID: 10509751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
    Wollin L; Bundschuh DS; Wohlsen A; Marx D; Beume R
    Pulm Pharmacol Ther; 2006; 19(5):343-52. PubMed ID: 16257550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a role of phosphodiesterase 4 in lipopolysaccharide-stimulated prostaglandin E2 production and matrix metalloproteinase-9 activity in human amniochorionic membranes.
    Oger S; Méhats C; Dallot E; Cabrol D; Leroy MJ
    J Immunol; 2005 Jun; 174(12):8082-9. PubMed ID: 15944316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
    Souness JE; Griffin M; Maslen C; Ebsworth K; Scott LC; Pollock K; Palfreyman MN; Karlsson JA
    Br J Pharmacol; 1996 Jun; 118(3):649-58. PubMed ID: 8762090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung.
    Escofier N; Boichot E; Germain N; Silva PM; Martins MA; Lagente V
    Fundam Clin Pharmacol; 1999; 13(1):96-101. PubMed ID: 10027094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevent to rheumatoid arthritis.
    Cho JY; Park JS; Baik KU; Lee JG; Kim HP; Yoo ES; Park MH
    Pharmacol Res; 2004 May; 49(5):423-31. PubMed ID: 14998551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats.
    Chi ZL; Hayasaka S; Zhang XY; Hayasaka Y; Cui HS
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2497-502. PubMed ID: 15277469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNF-alpha properties of new 9-benzyladenine derivatives with selective phosphodiesterase-4- inhibiting properties.
    Reimund JM; Raboisson P; Pinna G; Lugnier C; Bourguignon JJ; Muller CD
    Biochem Biophys Res Commun; 2001 Oct; 288(2):427-34. PubMed ID: 11606060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-alpha and neutrophil elastase.
    Kohyama T; Liu X; Zhu YK; Wen FQ; Wang HJ; Fang Q; Kobayashi T; Rennard SI
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):487-94. PubMed ID: 12356583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
    Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
    Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro.
    Jones NA; Boswell-Smith V; Lever R; Page CP
    Pulm Pharmacol Ther; 2005; 18(2):93-101. PubMed ID: 15649851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.